• Annexon appointed Mark S. Blumenkranz, a retinal surgeon and biotechnology entrepreneur, to its board of directors.
• Eleonora (Nora) Lad, Duke University ophthalmology professor and vice chair for clinical research, joined the scientific advisory board.
• Jake Shumacher joined as senior vice president, ophthalmology franchise head; he previously served as Astellas’ vice president, commercial head for IZERVAY.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annexon Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611091601PRIMZONEFULLFEED9873513) on November 09, 2026, and is solely responsible for the information contained therein.